Publikation
Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK
Wissenschaftlicher Artikel/Review - 01.07.2008
Borner M, Mingrone W, Lanz D, Dietrich D, Kappeler A, Roth A, Ruhstaller Thomas, Caspar C, Pestalozzi B, Helbling D, Trojan A, Hess V, Rauch D, Saletti P, von Moos R, Koeberle D, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
Borner, M
12
0
Koeberle, D
6
0
von Moos, R
25
0
Saletti, P
4
0
Rauch, D
7
0
Hess, V
7
0
Trojan, A
1
0
Helbling, D
2
0
Pestalozzi, B
6
0
Caspar, C
3
0
Ruhstaller, Thomas
83
24
Roth, A
3
0
Kappeler, A
2
0
Dietrich, D
8
0
Lanz, D
2
0
Mingrone, W
6
0
Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland,
4
0